Biolase (BIOL) Reports In-Line Q2 EPS, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BIOLASE Reports 2018 Second Quarter Results
August 8, 2018 8:30 AM EDTIRVINE, Calif., Aug. 8, 2018 /PRNewswire/ --Â BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for its second quarter and six months ended June 30, 2018.
Worldwide net revenue for the 2018 second quarter was $12.2 million compared to $12.6 million for the year-ago period, which included revenue from a large one-time purchase of non-core imaging... More



